TABLE 4.
Change in measured parameter | Placebo | Allopurinol | P value |
Uric acid (umol/l) | −1.33 ± 37.04 | −189.56 ± 91.95 | <0.001 |
HsCRP (mg/l) | −0.55 ± 2.10 | 0.22 ± 1.71 | 0.122 |
TBARS (μmol/l) | −0.34 ± 0.83 | 0.26 ± 0.85 | 0.007 |
NTProBNP (pg/ml) | 109.08 ± 491.03 | −109.03 ± 612.84 | 0.131 |
PICP (ng/l) | −0.18 ± 0.60 | −0.05 ± 0.43 | 0.322 |
Soluble ST2 (ng/ml) | −1.02 ± 3.39 | −0.61 ± 8.63 | 0.573 |
HsCRP, high-sensitivity C-reactive protein; NTproBNP, N-terminal pro B natriuretic peptide; PICP, N-terminal pro b-type natriuretic peptide; TBARs, thiobarbituric acid reactive substances.